A New Drug Against Severe Malaria – Part 3 of 3
But this additional study was needed because it was thought the disease course could be different in African children. “Artesunate should now become the treatment of choice for severe malaria for children and adults worldwide,” the authors of the inexperienced study concluded.
So “Malaria causes an estimated 800000 deaths every year in African children. Severe malaria is often the most common admission diagnosis in febrile children, so a switch in treatment policy from quinine to artesunate has the potential to save thousands of children’s lives every year,” White and colleagues stated in the news release. “If 4 million African children with inclement malaria every year were to receive prompt treatment with parenteral artesunate instead of quinine, and the benefits were similar to those recorded in this trial, then approximately 100000 lives might be saved per year,” they concluded.